US Food and Drug Administration officials are changing the agency's standards for updated COVID-19 booster shots with focus ...

FDA changes COVID-19 vaccine approval policy, major trials now required for widespread use. Higher risk individuals still have access.

The FDA has granted full approval for Novavax's COVID-19 vaccine, but with restrictions. Discover the details now.

A previous federal policy recommended an annual COVID shot for all Americans six months and older. Here is what the new proposal would be.

The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...

WEDNESDAY May 21, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) has decided that only seniors and ...

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years ...

Health experts say there are legitimate questions about how much everyone still benefits from yearly COVID vaccination or ...

Healthy younger adults and children will no longer be automatically approved for annual COVID-19 vaccines under a new policy from the FDA.

The policy has been outlined in an editorial in the New England Journal of Medicine (NEJM) by FDA Commissioner Marty Makary ...